Entero Healthcare Solutions Limited
ENTERO.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$72.95B
Close$
$-1460.72
187.1% downside
Current Fair Value
187.1% downsideOvervalued by 187.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $72.95 Billion |
|---|---|
| Enterprise Value | $72.95 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $26.44 |
| Beta | -0.61 |
| Outstanding Shares | 43,514,253 |
Return
| Return on Equity | 7.16% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 58.16 |
|---|---|
| PEG | 156.02 |
| Price to Sales | 1.02 |
| Price to Book Ratio | 4.17 |
| Enterprise Value to Revenue | 1.02 |
| Enterprise Value to EBIT | 26.88 |
| Enterprise Value to Net Income | 58 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$6.85
Average shareholder expectationRevenue Estimate
$18.37 B
Average shareholder expectationNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
$11.80
Average shareholder expectationRevenue Estimate
$20.14 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Entero Healthcare Solutions Limited
4,671 employees
CEO: Prabhat Agrawal Established in 2018 and headquartered in Mumbai, India, Entero Healthcare Solutions Limited functions as a key distributor within the Indian healthcare sector. The company specializes in supplying a diverse range of medical and health-re...